<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6906831/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <p>Trials correlating clinical features of patients with PD and T2DM.</p>
 </caption>
 <thead>
  <tr>
   <th align="left" rowspan="1" colspan="1" id="0-0-.">Influence of T2DM on PD</th>
   <th align="center" rowspan="1" colspan="1" id="0-1-.">Authors</th>
   <th align="center" rowspan="1" colspan="1" id="0-2-.">PD with T2DM/PD without T2DM</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" rowspan="1" colspan="1">Major cognitive impairment ( 
    <i>n</i> = 3) 
   </td>
   <td align="center" rowspan="1" colspan="1">Ong et al. [ 
    <a rid="B65" ref-type="bibr">65</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 11 
    <br/>PD without T2DM: 51 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="center" rowspan="1" colspan="1">Petrou et al. [ 
    <a rid="B66" ref-type="bibr">66</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 12 
    <br/>PD without T2DM: 24 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="center" rowspan="1" colspan="1">Bohnen et al. [ 
    <a rid="B67" ref-type="bibr">67</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 15 
    <br/>PD without T2DM: 133 
   </td>
  </tr>
  <tr>
   <td align="left" colspan="3" rowspan="1">
    <hr/>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Worsening of motor symptoms and/or postural instability ( 
    <i>n</i> = 4) 
   </td>
   <td align="center" rowspan="1" colspan="1">Mohamed Ibrahim et al. [ 
    <a rid="B68" ref-type="bibr">68</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 25 
    <br/>PD without T2DM: 25 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="center" rowspan="1" colspan="1">Pagano et al. [ 
    <a rid="B69" ref-type="bibr">69</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 21 
    <br/>PD without T2DM: 51 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="center" rowspan="1" colspan="1">Kotagal et al. [ 
    <a rid="B70" ref-type="bibr">70</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 13 
    <br/>PD without T2DM: 26 
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="center" rowspan="1" colspan="1">Cereda et al. [ 
    <a rid="B71" ref-type="bibr">71</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 466 
    <br/>PD without T2DM: 921 
   </td>
  </tr>
  <tr>
   <td colspan="3" rowspan="1">
    <hr/>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Influence of PD on T2DM</td>
   <td align="left" rowspan="1" colspan="1"> </td>
   <td align="left" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Reduction of glycemia and/or glycated hemoglobin and lipid profile improvement ( 
    <i>n</i> = 1) 
   </td>
   <td align="center" rowspan="1" colspan="1">Scheuing et al. [ 
    <a rid="B72" ref-type="bibr">72</a>] 
   </td>
   <td align="center" rowspan="1" colspan="1">PD with T2DM: 1579 
    <br/>PD without T2DM: 177.413 
   </td>
  </tr>
 </tbody>
</table>
